Intersect ENT Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Intersect ENT (XENT) Tops Q3 EPS by 10c
November 2, 2020 7:05 AM ESTIntersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $21.8 million.
Outlook:
As previously announced, due to the continued uncertainties resulting from the... More



